Asthma and COPD treatment: FDA approves generic of Symbicort
by Press Release from Outbreak News Today on (#5X52G)
Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions: asthma in patients six years of age and older; and the maintenance treatment of airflow obstruction and reducing exacerbations for patients with chronic obstructive pulmonary disease [...]
The post Asthma and COPD treatment: FDA approves generic of Symbicort appeared first on Outbreak News Today.